In a news release, Reliq Health Technologies Inc. (RHT:TSX.V; RQHTF:OTCQB; A2AJTB:WKN) announced that it has entered into a new contract with a Care Management Network, a group which includes more than 500 physicians and 50 clinics across the state of California. The firm stated that "the Network delivers culturally-customized, technology-enabled health care to senior citizens in the Asian-American community across California."
"We are very pleased to be expanding on the West Coast, and in particular to be leveraging our customizable, multilingual iUGO Care and iUGO Home solutions to meet the needs of Medicare, Medicaid and privately-insured patients in the Asian-American community in California...Using our highly scalable iUGO Care platform, physicians serving this community will be able to manage complex patients in their own homes and in their preferred language, offering multilingual Remote Patient Monitoring (RPM), Chronic Care Management (CCM) and Behavioral Health Integration (BHI) services," stated Reliq Health Technologies' CEO Dr. Lisa Crossley.
"With iUGO Home, case managers in the network can support seniors aging in place, allowing them to live safely and independently by providing multilingual personal emergency response services, fall detection, medication reminders and geofencing. We expect to begin onboarding patients in March, with an average revenue of US$40/patient/month," Dr. Lisa Crossley added.
Reliq Health indicated that its iUGO Care platform was created to support care coordination and community-based virtual healthcare. The company stated that iUGO Care facilitates high quality home care even for patients with complex medical issues and claimed that the platform aids in improving and enhancing patients health and quality of life while at the same time reducing medical care delivery costs. Reliq noted that iUGO Care offers real-time access to remote patient monitoring data, which permits timely and critical intervention by medical staff that in many cases reduces the need for expensive ER visits and hospital readmissions.
[NLINSERT]Disclosure:
1) Stephen Hytha compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. He or members of his household own securities of the following companies mentioned in the article: None. He or members of his household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: Reliq Health Technologies. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the decision to publish an article until three business days after the publication of the article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Reliq Health Technologies, a company mentioned in this article.
6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.
